Open AccessPanobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort
Author(s) -
Nadjoua Maouche,
Bhuvan Kishore,
Zara Bhatti,
Supratik Basu,
Farheen Karim,
Sharadha Sundararaman,
Freya Collings,
Bing Tseu,
Heather Leary,
Noel Ryman,
Udaya Reddy,
Grant Vallance,
Jaimal Kothari,
Karthik Ramasamy
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0270854
Subject(s) - medicine , panobinostat , bortezomib , dexamethasone , dosing , clinical endpoint , adverse effect , multiple myeloma , retrospective cohort study , refractory (planetary science) , clinical trial , oncology , surgery , physics , astrobiology , gene , histone , biochemistry , chemistry , histone deacetylase
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom